The putative reasons include lower socioeconomic status, missed or delayed diagnosis in new onset DM, poor adherence to therapy in known TIDM, and inadequate pre-referral optimization with fluids and insulin [16, 17]. This evidence concerns the gene INS and diabetes mellitus.